All In Biotech

Free tool

FAERS Monitor: Norvasc

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019787 or its brand name (Norvasc, Amlodipine Besylate). Reports on generic versions are filed under their own applications.

Reports

147,838

Serious

101,630

69% of reports

Hospitalization

54,341

Death reported

13,282

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue9,860
  • nausea8,456
  • diarrhoea8,041
  • dyspnoea8,012
  • drug ineffective7,201
  • pain6,914
  • dizziness6,652
  • headache6,590
  • asthenia5,824
  • pneumonia5,482
  • fall5,476
  • off label use5,428
  • vomiting5,427
  • hypertension5,232
  • death4,914

Reports by year received

View as table
YearReports
20043,379
20053,869
20064,019
20073,206
20083,180
20093,982
20105,808
20116,230
20126,673
20134,898
20146,580
20157,687
20168,465
20177,500
20187,955
20197,850
20207,320
20217,565
20229,886
20238,342
20248,301
20258,803
20266,327

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,906,321 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypertensionSignal5,2323.63.59,573
pneumoniaSignal5,4822.42.44,619
fallSignal5,4762.42.34,302
astheniaSignal5,8242.22.23,925
dyspnoeaSignal8,0122.02.04,229
dizziness6,6521.91.92,912
fatigue9,8601.81.83,678
diarrhoea8,0411.81.72,810
vomiting5,4271.61.61,403
pain6,9141.61.61,619
nausea8,4561.51.51,574
headache6,5901.51.51,122
off label use5,4280.90.990
death4,9140.80.8226
drug ineffective7,2010.80.8493

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.